These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 31672622)

  • 1. A two-step precise targeting nanoplatform for tumor therapy via the alkyl radicals activated by the microenvironment of organelles.
    Wang L; Niu X; Song Q; Jia J; Hao Y; Zheng C; Ding K; Xiao H; Liu X; Zhang Z; Zhang Y
    J Control Release; 2020 Feb; 318():197-209. PubMed ID: 31672622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of triple negative breast cancer by near infrared light triggered mild-temperature photothermal therapy combined with oxygen-independent cytotoxic free radicals.
    Li R; Hu X; Shang F; Wu W; Zhang H; Wang Y; Pan J; Shi S; Dong C
    Acta Biomater; 2022 Aug; 148():218-229. PubMed ID: 35705171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoplatform based on GSH-responsive mesoporous silica nanoparticles for cancer therapy and mitochondrial targeted imaging.
    He H; Meng S; Li H; Yang Q; Xu Z; Chen X; Sun Z; Jiang B; Li C
    Mikrochim Acta; 2021 Apr; 188(5):154. PubMed ID: 33821295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor microenvironment responsive VEGF-antibody functionalized pH sensitive liposomes of docetaxel for augmented breast cancer therapy.
    Jain S; Deore SV; Ghadi R; Chaudhari D; Kuche K; Katiyar SS
    Mater Sci Eng C Mater Biol Appl; 2021 Feb; 121():111832. PubMed ID: 33579470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound-Triggered Destruction of Folate-Functionalized Mesoporous Silica Nanoparticle-Loaded Microbubble for Targeted Tumor Therapy.
    Lv Y; Cao Y; Li P; Liu J; Chen H; Hu W; Zhang L
    Adv Healthc Mater; 2017 Sep; 6(18):. PubMed ID: 28671341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondria-targeting folic acid-modified nanoplatform based on mesoporous carbon and a bioactive peptide for improved colorectal cancer treatment.
    Wang J; Zhang L; Xin H; Guo Y; Zhu B; Su L; Wang S; Zeng J; Chen Q; Deng R; Wang Z; Wang J; Jin X; Gui S; Xu Y; Lu X
    Acta Biomater; 2022 Oct; 152():453-472. PubMed ID: 36084923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondria-targeted accumulation of oxygen-irrelevant free radicals for enhanced synergistic low-temperature photothermal and thermodynamic therapy.
    Hu H; Deng X; Song Q; Yang W; Zhang Y; Liu W; Wang S; Liang Z; Xing X; Zhu J; Zhang J; Shao Z; Wang B; Zhang Y
    J Nanobiotechnology; 2021 Nov; 19(1):390. PubMed ID: 34823543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifunctional nanoparticles for enhanced sonodynamic-chemodynamic immunotherapy with glutathione depletion.
    Song J; Tang C; Wang Y; Ba J; Liu K; Gao J; Chang J; Kang J; Yin L
    Nanomedicine (Lond); 2024 Jan; 19(2):145-161. PubMed ID: 38270976
    [No Abstract]   [Full Text] [Related]  

  • 9. Triphenylphosphine-docetaxel conjugate-incorporated albumin nanoparticles for cancer treatment.
    Battogtokh G; Gotov O; Kang JH; Cho J; Jeong TH; Chimed G; Ko YT
    Nanomedicine (Lond); 2018 Feb; 13(3):325-338. PubMed ID: 29338573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Cu-based nanoplatform for near-infrared light amplified multi-mode prostate cancer specific therapy.
    Xu B; Niu R; Tang Y; Wang C; Jin L; Wang Y
    J Mater Chem B; 2022 Sep; 10(37):7628-7633. PubMed ID: 35894661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid modified lipid-bilayer coated mesoporous silica nanoparticles co-loading paclitaxel and tanshinone IIA for the treatment of acute promyelocytic leukemia.
    Li Z; Zhang Y; Zhu C; Guo T; Xia Q; Hou X; Liu W; Feng N
    Int J Pharm; 2020 Aug; 586():119576. PubMed ID: 32603839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pH-responsive sequential-disassembly nanohybrid for mitochondrial targeting.
    Li L; Sun W; Li L; Liu Y; Wu L; Wang F; Zhou Z; Zhang Z; Huang Y
    Nanoscale; 2017 Jan; 9(1):314-325. PubMed ID: 27910990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel near-infrared triggered dual-targeted nanoplatform for mitochondrial combined photothermal-chemotherapy of cancer in vitro.
    Wu H; You C; Jiao J; Chen F; Sun B; Zhu X
    Nanotechnology; 2019 Jan; 30(3):035601. PubMed ID: 30418947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEGylated polyaminoacid-capped mesoporous silica nanoparticles for mitochondria-targeted delivery of celastrol in solid tumors.
    Choi JY; Gupta B; Ramasamy T; Jeong JH; Jin SG; Choi HG; Yong CS; Kim JO
    Colloids Surf B Biointerfaces; 2018 May; 165():56-66. PubMed ID: 29453086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polypyrrole-coated phase-change liquid perfluorocarbon nanoparticles for the visualized photothermal-chemotherapy of breast cancer.
    Yang Q; Li P; Ran H; Wan J; Chen H; Chen H; Wang Z; Zhang L
    Acta Biomater; 2019 May; 90():337-349. PubMed ID: 30936037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metal-Organic Framework (MOF)-Based Ultrasound-Responsive Dual-Sonosensitizer Nanoplatform for Hypoxic Cancer Therapy.
    Zhang C; Xin L; Li J; Cao J; Sun Y; Wang X; Luo J; Zeng Y; Li Q; Zhang Y; Zhang T; Huang P
    Adv Healthc Mater; 2022 Jan; 11(2):e2101946. PubMed ID: 34706160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of water-soluble radical initiator, 2,2'-azobis[2-(2-imidazolin-2-yl)propane] dihydrochloride, to a study of oxidative stress.
    Yoshida Y; Itoh N; Saito Y; Hayakawa M; Niki E
    Free Radic Res; 2004 Apr; 38(4):375-84. PubMed ID: 15190934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesoporous silica nanoparticles functionalized with folic acid/methionine for active targeted delivery of docetaxel.
    Khosravian P; Shafiee Ardestani M; Khoobi M; Ostad SN; Dorkoosh FA; Akbari Javar H; Amanlou M
    Onco Targets Ther; 2016; 9():7315-7330. PubMed ID: 27980423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid (FA)-conjugated mesoporous silica nanoparticles combined with MRP-1 siRNA improves the suppressive effects of myricetin on non-small cell lung cancer (NSCLC).
    Song Y; Zhou B; Du X; Wang Y; Zhang J; Ai Y; Xia Z; Zhao G
    Biomed Pharmacother; 2020 May; 125():109561. PubMed ID: 32106385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mitochondria-targeted multifunctional nanoplatform combining carbon monoxide delivery with O
    Zhang HL; Wang Y; Tang Q; Wang CB; Chen MJ; Yang SP; Liu JG
    Colloids Surf B Biointerfaces; 2023 Oct; 230():113513. PubMed ID: 37579528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.